Pre-launch · We're opening Reserve Meds to a limited first cohort. Join the waitlist ›

Spinal Muscular Atrophy in Jordan

How patients in Jordan access treatment for spinal muscular atrophy via Named Patient Program.

About Spinal Muscular Atrophy

Neuromuscular

Treatment access in Jordan

Jordan's JFDA operates a compassionate-use framework for unregistered drugs; requires physician and JFDA approval.

For patients in Jordan with spinal muscular atrophy whose required therapy is not locally registered, a Named Patient Program pathway typically applies.

How Reserve Meds supports patients with spinal muscular atrophy in Jordan

  1. Patient or physician contacts us with disease details and therapy requested.
  2. We verify eligibility in Jordan and confirm US supply.
  3. Treating physician in Jordan issues prescription and justification.
  4. We file Jordan-specific NPP/personal-import paperwork.
  5. We source the drug from a DSCSA-compliant US specialty wholesaler.
  6. Cold-chain shipment to the patient's physician or hospital pharmacy in Jordan.

Patient support throughout

  • Case manager from request through delivery.
  • Documentation translation where needed.
  • Physician-to-physician support for clinical justification.
  • Re-supply coordination for chronic therapy.

Start a request

Start a Spinal Muscular Atrophy request in Jordan

Review & oversight. Content on this page is reviewed by Reserve Meds's clinical and regulatory team. A US-licensed pharmacist reviews every prescription before dispensing. Regulatory posture is informational, not legal advice; case-specific questions route to retained outside counsel. Review methodology ›
Last medically reviewed: .